Showing 26,021 - 26,040 results of 37,017 for search '(( 50 ((ng decrease) OR (nn decrease)) ) OR ( 16 ((mean decrease) OR (a decrease)) ))', query time: 0.91s Refine Results
  1. 26021
  2. 26022

    Table_2_Alteration of Porcine Intestinal Microbiota in Response to Dietary Manno-Oligosaccharide Supplementation.DOCX by En Yu (12069566)

    Published 2022
    “…Moreover, MOS elevated the expression level of SCL5A8 and GPR109A but decreased the expression levels of HDAC1 and TNF-α in the ileal and cecal mucosa (p < 0.05). …”
  3. 26023

    Knock-down of ADAR1. by Michal Ben-Zvi (471371)

    Published 2013
    “…<p>LB cells were transfected with si-ADAR1 or with a control si molecule (siControl). Cells were either treated with DFO 16h post-transfection or untreated. …”
  4. 26024

    Table_1_Alteration of Porcine Intestinal Microbiota in Response to Dietary Manno-Oligosaccharide Supplementation.DOCX by En Yu (12069566)

    Published 2022
    “…Moreover, MOS elevated the expression level of SCL5A8 and GPR109A but decreased the expression levels of HDAC1 and TNF-α in the ileal and cecal mucosa (p < 0.05). …”
  5. 26025

    Image_1_Alteration of Porcine Intestinal Microbiota in Response to Dietary Manno-Oligosaccharide Supplementation.TIF by En Yu (12069566)

    Published 2022
    “…Moreover, MOS elevated the expression level of SCL5A8 and GPR109A but decreased the expression levels of HDAC1 and TNF-α in the ileal and cecal mucosa (p < 0.05). …”
  6. 26026
  7. 26027
  8. 26028
  9. 26029
  10. 26030
  11. 26031

    Voluntary wheel running can lead to modulation of immune checkpoint molecule expression by Marie Lund Bay (9382997)

    Published 2020
    “…We did, however, not find an additive effect of combining either of the two immunotherapeutic treatments with access to running wheels.</p> <p> B16 tumors displayed upregulated expression of immune regulatory molecules and decreased tumor growth in response to PA. …”
  12. 26032
  13. 26033
  14. 26034

    Data_Sheet_1_Antioxidant and Anti-atherogenic Properties of Prosopis strombulifera and Tessaria absinthioides Aqueous Extracts: Modulation of NADPH Oxidase-Derived Reactive Oxygen... by Isabel Quesada (11144235)

    Published 2021
    “…Under high-fat diet (HFD), both extracts were able to inhibit O<sub>2</sub><sup>–</sup> generation in the aortic tissue and caused a significant regression of atheroma plaques (21.4 ± 1.6% HFD group vs. 10.2 ± 1.2%<sup>∗</sup> AEPs group and 14.3 ± 1.0%<sup>∗</sup> AETa group; <sup>∗</sup>p < 0.01). …”
  15. 26035
  16. 26036
  17. 26037

    The role of Cathepsin inhibitors in RGC damage in hypoxic retina. by Emi Nakajima (21703141)

    Published 2025
    “…Treatment with neither Odanacatib nor SID26681509 reduced the percentage of PI-positive RGCs, whereas the positive control SNJ-1945 significantly decreased the percentage. Data are means ± SD (n = 3). …”
  18. 26038

    Image 3_Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors.tif by Jinming Yang (366356)

    Published 2025
    “…</p>Results<p>Both palbociclib and SX-682 inhibited the growth of BRAF<sup>WT</sup>/NRAS<sup>WT</sup> B16-F10 and NRAS<sup>mut</sup> 1014 melanoma tumors and in both models, SX-682 created a more anti-tumor immune microenvironment. …”
  19. 26039

    Image 1_Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors.tif by Jinming Yang (366356)

    Published 2025
    “…</p>Results<p>Both palbociclib and SX-682 inhibited the growth of BRAF<sup>WT</sup>/NRAS<sup>WT</sup> B16-F10 and NRAS<sup>mut</sup> 1014 melanoma tumors and in both models, SX-682 created a more anti-tumor immune microenvironment. …”
  20. 26040

    Image 2_Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors.tif by Jinming Yang (366356)

    Published 2025
    “…</p>Results<p>Both palbociclib and SX-682 inhibited the growth of BRAF<sup>WT</sup>/NRAS<sup>WT</sup> B16-F10 and NRAS<sup>mut</sup> 1014 melanoma tumors and in both models, SX-682 created a more anti-tumor immune microenvironment. …”